Another COVID-19 vaccine from China has applied for emergency use approval (EUA) in the Philippines.

Sinopharm, a state-owned pharmaceutical company in China has officially filed an application for an EUA at the Philippines’ Food and Drug Administration (FDA) for its Covid-19 vaccines.

“It has been filed. They have already filed with the FDA an application for EUA for Sinopharm vaccine,” confirmed Presidential Spokesperson Harry Roque in a press conference in Manila.

RELATED STORY: Duterte thanks China for timely donation of 600,000 doses of Sinovac to PH

FDA Director-General Eric Domingo has yet to confirm Sinopharm’s EUA application.

On Feb. 22, Roque said President Rodrigo Duterte prefers to get inoculated with the Sinopharm vaccine.

FDA granted Duterte’s security detail a compassionate permit for the use of 10,000 doses of Sinopharm vaccine last month, as per reports from the Philippine News Agency.

The Presidential Security Group admitted to vaccinating some of its members in September and October 2020.

READ ON: Duterte, mas gustong magpaturok ng Sinopharm na dumaan sa human clinical trial sa UAE

Roque said Duterte is also qualified to receive vaccine shots from Sinopharm under the compassionate use license since he is the commander-in-chief of the military.

Since the Sinopharm has filed its application, it remains to be seen whether Duterte would wait for the FDA’s EUA before receiving his shot or get the jab under compassionate use.

“It will take around 21 days more or less for the FDA to act on the application that has been filed today so hindi ko po alam (I don’t know) when the legal opinion of the Malacañang legal office will come out on whether or not he can have his shot under the compassionate use, so whichever comes first,” he said.

Currently, Duterte’s possible inoculation with the Sinopharm vaccine under the compassionate use license is being studied by the Malacañang legal office.

The post Sinopharm applies for emergency use approval in PH appeared first on The Filipino Times.